Blueprint Medicines Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 9 | -$1.91 | -$1.47 | -$1.67 |
| Q2 2024 | 4 | -$1.48 | -$1.13 | -$1.29 |
| Q3 2024 | 8 | -$1.10 | -$0.85 | -$0.96 |
| Q4 2024 | 14 | -$1.63 | $1.95 | -$0.68 |
| Q1 2025 | 7 | -$0.80 | -$0.46 | -$0.56 |
| Q2 2025 | 3 | -$0.49 | -$0.38 | -$0.43 |
| Q3 2025 | 6 | -$0.30 | -$0.23 | -$0.26 |
| Q4 2025 | 5 | -$0.13 | -$0.10 | -$0.11 |
| Q1 2026 | 4 | $0.97 | $1.26 | $1.10 |
| Q2 2026 | 3 | $0.98 | $1.27 | $1.11 |
| Q3 2026 | 2 | $0.98 | $1.29 | $1.12 |
Blueprint Medicines Corporation Earnings Date And Information
Blueprint Medicines Corporation last posted its earnings results on Wednesday, October 30th, 2024. The company reported $-0.89 earnings per share for the quarter, topping analysts' consensus estimates of $-0.97 by $0.08. The company had revenue of 128.18 M for the quarter and had revenue of 249.38 M for the year. Blueprint Medicines Corporation has generated $-8 earnings per share over the last year ($-8.37 diluted earnings per share) and currently has a price-to-earnings ratio of -45.48. Blueprint Medicines Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Blueprint Medicines Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/30/2024 | Q3 2024 | -$0.97 | -$0.89 | 0.08 | $127.56 M | $128.18 M |
| 08/01/2024 | Q2 2024 | -$1.28 | -$0.80 | 0.48 | $104.02 M | $138.16 M |
| 05/02/2024 | Q1 2024 | -$1.64 | $1.45 | 3.09 | $96.12 M | |
| 02/15/2024 | Q4 2023 | -$2.04 | -$1.82 | 0.22 | $71.96 M | |
| 10/26/2023 | Q3 2023 | -$2.39 | -$2.20 | 0.19 | $50.66 M | $56.57 M |
| 08/02/2023 | Q2 2023 | -$2.58 | -$2.19 | 0.39 | $45.60 M | $57.57 M |
| 05/04/2023 | Q1 2023 | -$2.66 | -$2.15 | 0.51 | $63.29 M | |
| 02/16/2023 | Q4 2022 | -$2.73 | -$2.65 | 0.08 | $38.78 M | |
| 11/01/2022 | Q3 2022 | -$2.51 | -$2.23 | 0.28 | $43.51 M | $65.98 M |
| 08/02/2022 | Q2 2022 | -$2.23 | -$2.68 | -0.45 | $37.28 M | $36.55 M |
| 05/03/2022 | Q1 2022 | -$1.79 | -$1.79 | 0 | $62.73 M | |
| 02/17/2022 | Q4 2021 | -$5.40 | $107.02 M | |||
| 10/28/2021 | Q3 2021 | -$1.69 | -$2.00 | -0.31 | $42.50 M | $24.19 M |
| 07/29/2021 | Q2 2021 | -$1.77 | -$1.86 | -0.09 | $23.21 M | $27.30 M |
| 04/29/2021 | Q1 2021 | -$1.80 | -$1.72 | 0.08 | $21.58 M | |
| 02/17/2021 | Q4 2020 | -$1.57 | -$1.53 | 0.04 | $34.11 M | |
| 10/29/2020 | Q3 2020 | $7.72 | $11.49 | 3.77 | $627.42 M | $745.12 M |
| 07/30/2020 | Q2 2020 | -$2.08 | -$2.28 | -0.2 | $7.17 M | $8.34 M |
| 05/06/2020 | Q1 2020 | -$2.15 | -$2.11 | 0.04 | $6.17 M | |
| 02/13/2020 | Q4 2019 | -$1.71 | -$1.35 | 0.36 | $51.53 M |
Blueprint Medicines Corporation Earnings: Frequently Asked Questions
-
When is Blueprint Medicines Corporation's earnings date?
Blueprint Medicines Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates.
-
Did Blueprint Medicines Corporation beat their earnings estimates last quarter?
In the previous quarter, Blueprint Medicines Corporation (:BPMC) reported $-0.89 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.97 by $0.08.
-
How can I listen to Blueprint Medicines Corporation's earnings conference call?
The conference call for Blueprint Medicines Corporation's latest earnings report can be listened to online.
-
How can I read Blueprint Medicines Corporation's conference call transcript?
The conference call transcript for Blueprint Medicines Corporation's latest earnings report can be read online.
-
How much revenue does Blueprint Medicines Corporation generate each year?
Blueprint Medicines Corporation (:BPMC) has a recorded annual revenue of $249.38 M.
-
How much profit does Blueprint Medicines Corporation generate each year?
Blueprint Medicines Corporation (:BPMC) has a recorded net income of $249.38 M. Blueprint Medicines Corporation has generated $-8.37 earnings per share over the last four quarters.
-
What is Blueprint Medicines Corporation's price-to-earnings ratio?
Blueprint Medicines Corporation (:BPMC) has a price-to-earnings ratio of -45.48 and price/earnings-to-growth ratio is -1.18.
